2) To facilitate comparisons of survival outcomes across hospitals in an equitable way (i.e., adjust for patient case-mix), we derived and validated a model to risk-standardize survival outcomes after in-hospital cardiac arrest.
3) An initial prediction model of 18 variables was reduced to 9 final variables. These factors included: age group; initial cardiac arrest rhythm; hospital location of arrest; the presence of hypotension (abnormally low blood pressure), sepsis, metastatic or hematologic malignancy, or hepatic insufficiency prior to cardiac arrest; or requirement of mechanical ventilation of continuous vasopressor infusion at the time of cardiac arrest.
4) The risk-standardization model had good discrimination (c-statistic of 0.734) and calibration statistics and was validated internally within the registry. 5) Risk-standardization re-classified many hospitals' performance. More than half of the hospitals in the study had at least a 10% positive or negative absolute change in percentile ranking after risk-standardization, and 23% of hospitals had a >20% absolute change in percentile ranking. 6) After risk-standardization, there remained significant variation in survival outcomes for in-hospital cardiac arrest among hospitals. This suggests that use of this model can support efforts to compare outcomes in resuscitation care across hospitals.
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